Eagle Pharmaceuticals, Inc. (EGRX)
OTCMKTS
· Delayed Price · Currency is USD
0.650
0.00 (0.00%)
Dec 18, 2024, 4:00 PM EST
Eagle Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2013 |
| Net Income | 11.95 | 35.64 | -8.63 | 11.99 | 14.31 | 31.9 | Upgrade
|
| Depreciation & Amortization | 21.92 | 13.27 | 4.81 | 4.77 | 4.65 | 3.67 | Upgrade
|
| Other Amortization | 0.46 | 0.47 | 0.47 | 0.42 | 0.48 | 0.38 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 8.47 | Upgrade
|
| Loss (Gain) From Sale of Investments | 1.42 | 4.46 | 6.17 | 5.3 | - | - | Upgrade
|
| Stock-Based Compensation | 16.49 | 16.45 | 19.56 | 24.76 | 22 | 19.08 | Upgrade
|
| Other Operating Activities | -3.92 | -3.18 | -3.69 | 1.45 | 0.15 | -3.23 | Upgrade
|
| Change in Accounts Receivable | -29.22 | -30.83 | 9.53 | -3.11 | 18.48 | -12.67 | Upgrade
|
| Change in Inventory | 5.1 | -8.34 | -13.83 | -1.51 | 1.74 | -5.56 | Upgrade
|
| Change in Accounts Payable | -3.12 | 2.97 | 10.16 | 0.81 | -4.46 | -2.06 | Upgrade
|
| Change in Other Net Operating Assets | -30.4 | 19.8 | 3.68 | 4.63 | -1.37 | 12.4 | Upgrade
|
| Operating Cash Flow | -9.32 | 50.7 | 28.22 | 49.5 | 55.99 | 52.38 | Upgrade
|
| Operating Cash Flow Growth | - | 79.67% | -42.99% | -11.59% | 6.88% | -11.09% | Upgrade
|
| Capital Expenditures | -0.07 | -0.18 | -0.32 | -0.75 | -0.78 | -0.13 | Upgrade
|
| Cash Acquisitions | 1.26 | -74.15 | - | - | - | - | Upgrade
|
| Investment in Securities | -25 | -12.5 | - | -17.5 | - | - | Upgrade
|
| Other Investing Activities | - | - | -5 | - | - | - | Upgrade
|
| Investing Cash Flow | -23.81 | -86.83 | -5.32 | -18.25 | -0.78 | -0.13 | Upgrade
|
| Short-Term Debt Issued | - | 30 | - | 110 | - | - | Upgrade
|
| Long-Term Debt Issued | - | 50 | - | - | - | - | Upgrade
|
| Total Debt Issued | 110 | 80 | - | 110 | - | - | Upgrade
|
| Short-Term Debt Repaid | - | -15 | - | -110 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -52.24 | -8 | -5 | -6 | -3.75 | Upgrade
|
| Total Debt Repaid | -85.74 | -67.24 | -8 | -115 | -6 | -3.75 | Upgrade
|
| Net Debt Issued (Repaid) | 24.26 | 12.76 | -8 | -5 | -6 | -3.75 | Upgrade
|
| Issuance of Common Stock | 0.25 | 1.75 | 2.4 | 3.65 | 0.26 | 8.62 | Upgrade
|
| Repurchase of Common Stock | -11.23 | -19.36 | -22.79 | -36.52 | -18.16 | -73.11 | Upgrade
|
| Other Financing Activities | -1.36 | -1.36 | - | - | -0.33 | -19.88 | Upgrade
|
| Financing Cash Flow | 11.92 | -6.21 | -28.39 | -37.87 | -24.23 | -88.12 | Upgrade
|
| Net Cash Flow | -21.21 | -42.34 | -5.5 | -6.62 | 30.98 | -35.87 | Upgrade
|
| Free Cash Flow | -9.39 | 50.52 | 27.9 | 48.75 | 55.21 | 52.25 | Upgrade
|
| Free Cash Flow Growth | - | 81.11% | -42.78% | -11.70% | 5.66% | -4.10% | Upgrade
|
| Free Cash Flow Margin | -3.65% | 15.96% | 16.26% | 25.96% | 28.18% | 24.50% | Upgrade
|
| Free Cash Flow Per Share | -0.71 | 3.87 | 2.14 | 3.54 | 3.90 | 3.42 | Upgrade
|
| Cash Interest Paid | 4.06 | 1.73 | 1.2 | 2.22 | - | 2.08 | Upgrade
|
| Cash Income Tax Paid | 37.2 | 28.41 | 10.01 | 6.43 | 6.67 | 2.28 | Upgrade
|
| Levered Free Cash Flow | 38.31 | 87.63 | 31.68 | 50.08 | 54.07 | 30.32 | Upgrade
|
| Unlevered Free Cash Flow | 41.66 | 89.68 | 32.23 | 51.27 | 55.27 | 31.66 | Upgrade
|
| Change in Net Working Capital | 22.74 | 2.64 | -6.46 | -1.9 | -15.77 | 20 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.